Sentences with phrase «by pharma companies»

A lot of commenters have been expecting that challenge to turn into more money spent by pharma companies on biotech; but the Abbott - Piramal transaction emphasized that there's more than one way... [more]
Similarly, innovation in collaborative, patient - centric drug development models that are being promoted by pharma companies, regulators and patient groups, have the ability to transform the industry and improve productivity significantly.
Today, at 2 p.m. Eastern, the President will sign the 21st Century Cures Act — approved by the Senate on Dec. 7 by a vote of 94 - to - 5, overwhelmingly passed by the House the week before, and seemingly supported by every pharma company, medical institution, healthcare advocate and their mothers.
This guy is simply talking CRAP and has been handed over a script by some Pharma company.

Not exact matches

In B.C. especially, companies such as QLT Inc., Angiotech Pharmaceuticals and Cardiome Pharma Corp. saw their valuations soar in the early 2000s, only to come crashing to earth by the end of the decade as a result of competitive pressures, regulatory snags, strategic blunders and deals gone awry.
Shkreli originally became infamous for his other former company Turing Pharma's 5,000 % price hike for a drug used by cancer and AIDS patients.
But the initiative comes with another huge financial prize for firms that successfully win FDA approval for these niche therapies: a priority review voucher that can be used to slash the regulatory period for a different experimental specialty treatment being developed by a drug maker or, more often, sold for potentially hundreds of millions of dollars to another pharma company.
Big biotech and pharma companies are absolutely dependent on being able to successfully innovate by partnering with and acquiring disruptive startups because of the nature of the patent cliff in pharmaceuticals.
Martin Shkreli, unaffectionately known as the «pharma bro» — and infamous for his decision to hike the list price of Daraprim, a drug used by HIV / AIDS and cancer patients to combat infections, by more than 5,000 % in 2015 under his former company Turing Pharmaceuticals — was convicted on three criminal securities fraud and conspiracy charges by a Brooklyn jury on Friday.
She speculates that the company strengthened its bonds with customers by taking a stand against Big Pharma.
This can set you up also for more long term reputation rehabilitation by forcing a focus on Turing as a research and development company — not a pharma hedge fund hybrid.»
The latest pharma innovation report from Deloitte holds some pretty grim news for pharma: returns on R&D investments by large cap companies slid to a mere 3.7 % in 2016, down from the 10.1 % returns seen in 2010 (although the cost of bringing a drug to market is beginning to stabilize).
At one time blocked by the FDA, 23 & Me is now a smash hit with both consumers and pharma companies.
Ten of these companies, our honorees, have matched or outperformed the median annual revenue or profit for their peers in pharma, biotech, or tech, as tracked by EY and Capital IQ.
Many of the recent Big Pharma deals and acquisition proposals have been motivated by the companies» desire to lower their tax rate by acquiring a foreign rival and moving their headquarters overseas in a process known as an inversion.
By printing multiple lung airways — or any other afflicted organ — from a human patient and testing drugs on them, pharma companies can bypass the ethically challenged practice of testing on animals and proceed to human clinical trials with greater confidence the drugs will actually work, according to Wadsworth.
At a moment when the world's fourth - largest pharmaceutical company by sales (Pfizer) is eagerly courting the world's ninth - largest (the very same AstraZeneca from which Bristol decoupled)-- offering, in late May, a monumental dowry of around $ 120 billion — one can be forgiven for not noticing the more substantive change that's sweeping the pharmaceutical industry: Big Pharma is getting smaller.
But as these recent fiery debates within the drug industry underscore, pharma's price hike tactics, now under constant public scrutiny, may well lead to more far - reaching change — whether imposed by legislation or by biopharma companies upon themselves.
Drug companies including Purdue Pharma LP and Johnson & Johnson have been fighting lawsuits by two California counties, the city of Chicago, four counties in New York and the state of Mississippi over their opioid marketing practices.
A Reuters report citing sources who say that the firm is in talks with investment backs after being approached by several pharma companies for a buyout.
Antares Pharma (ATRS)- The company possesses a strong pipeline of drug / device combination product candidates which provide better treatment options in a variety of disease settings - Xyosted could potentially be approved by September and should see significant adoption due to several advantages over current treatments (keep in mind global male hypogonadism market to exceed $ 3 billion within 10 years).
On Monday, United Therapeutics reached a deal to acquire Israel - based SteadyMed Therapeutics Inc. in a deal potentially valued at US$ 216mln, a move that eliminates a serious competitive threat to the Maryland biotech by literally pulling the speciality pharma company into its own corner.
The HHS secretary went on to say that his agency wanted to find ways for Medicaid and Medicare to bring drug prices down by creating more resources to negotiate with pharma companies.
A 2017 investigation into lobbying efforts by «Big Pharma» conducted by The Washington Post and 60 Minutes found that the companies spent more than $ 106 million to lobby Congress in an effort to pass more favorable drug laws.
June 6 - 7 Chicago: American Packaging Summit 2018, brings together leaders from across all industry sectors: food and beverage, CPG, cosmetics, pharma, retail, toys and more — involved in the business of packaging, discussing current trends, strategic insights and best practices in packaging innovation, design, materials and branding at the Hyatt Regency O'Hare, organized by Toronto - based company the Generis Group.
While Williams built his reputation on deals such as the merger of fertiliser giants Incitec and Pivot and more recently by advising Bega Cheese in the takeover battle of Warrnambool Cheese & Butter, he has dabbled in small pharma companies for years.
The so - called «Pharma Bro,» notorious for raising the price of a potentially life - saving drug by 5,000 percent, was found guilty today of defrauding investors in two hedge funds and in Retrophin Inc., a pharmaceutical company he co-founded.
Common Cause says the Moreland Commission should open a probe to see if there's a link between around $ 5 million spent by major pharmaceutical companies on lobbying and campaign donations to New York state politicians, and the failure to pass major consumer - friendly bills regulating Big Pharma.
They started by looking at how other pharma companies were using Social Media.
Backed by an extensive offering of premium laboratory instruments, consumables and services, the LPS division concentrates on serving the needs of laboratories performing research and quality assurance at pharma and biopharma companies and on those in academic research institutes.
Individuals working in human resources at biotech and pharma companies (Science Careers sales database) were also contacted by e-mail and asked to promote the survey within their organization.
If a pharma company can find a way to temporarily disable those molecules (most likely by blocking their receptor, PirB), that secondary damage might be avoided, and the brain might also do a better job of repairing itself.
«The acquisitions within the pharma industry are symptomatic of many companies with relatively weak pipelines that are acquiring innovation by consolidating with larger companies to reduce expenses.»
Roughly 25 % of respondents were contacted by direct email; the remaining 75 % of surveys were returned following promotion by 573 contacts in human resources at biotech and pharma companies (Science Careers database).
Roughly three - quarters of respondents work in private industry, with 47 percent employed by biotechnology companies, 33 percent in pharmas, and the remaining 20 percent in biopharmas.
Creating new opportunities for «all of these very talented, experienced, displaced workers» requires «getting them thinking creatively about maybe making the move from big pharma, where they've spent their careers,» to other opportunities, such as smaller, newer companies created by themselves, perhaps, or other displaced scientists.
One of the most important ways they're doing this is by, in effect, outsourcing early - stage research and development to smaller pharma and biotech companies.
Daniel Getts, chief scientific officer of Cour Pharma in Chicago, Illinois, says he has written WHO to suggest the use of his company's Immune Modifying Nanoparticles, designed to reduce tissue damage by binding immune cells called monocytes.
Like many successful biotechs, CAT was snapped up by a big pharma company last year.
Another area that big pharma has traditionally been reluctant to get involved with is research into orphan diseases — ones that affect so few people that working on them is not usually considered commercially viable by large companies.
Last July, Novartis Pharma admitted that a former employee created a conflict of interest by participating in clinical studies of valsartan, sold under the trade name Diovan, conducted by five Japanese medical schools while concealing his affiliation with the company.
The new tests were led by Santaris Pharma, a biotech company in Horsholm, Denmark, focused on developing microRNA - based therapies.
Table 1: Selection, Design & Construction of HSV - based Oncolytic Viruses Table 2: Selection, Design & Construction of Adenovirus - based Oncolytic Viruses Table 3: Selection, Design & Construction of Vaccinia Virus - based Oncolytic Viruses Table 4: Selection, Design & Construction of Vesicular Stomatitis Virus - based Oncolytic Viruses Table 5: Selection, Design & Construction of Newcastle Disease Virus - based Oncolytic Viruses Table 6: Selection, Design & Construction of Various Virus - based Oncolytic Viruses Table 7: Current Company - Sponsored Clinical Trials of T - Vec Table 8: Clinical Trials of ColoAd1 Table 9: Clinical Trials with JX - 594 Table 10: Clinical Trials with GL - ONC1 Table 11: Clinical Trials of CAVATAK (CVA21) Table 12: Clinical Trials with MV - NIS Table 13: Overview of Oncolytic Viruses by Development Phase & Virus Family Table 14: Profile of Approved and Marketed Oncolytic Viruses Table 15: Pivotal Study Design of Oncolytic Viruses in Late Stage Development Based on Previous Clinical Results Table 16: Approved Indications of Immune Checkpoint Inhibitors Table 17: Active Clinical Studies of Oncolytic Viruses in Combination with Immune Checkpoint Inhibitors (ICI) Table 18: Planned Clinical Studies of Oncolytic Viruses in Combination with Immune Checkpoint Inhibitors (ICI) Table 19: Active or Planned Clinical Studies of Oncolytic Viruses in Combination with Other Anti-Cancer Therapeutics Table 20: Pattern of Transgenes in Oncolytic Viruses in Relation to Development Phase Tables 21a and 21b: Indications and Frquency and Way of Administration of Oncolytic Viruses in Active and / or Positive Completed Clinical Studies Table 22: Small and Medium Pharma & Biotech as Partner for Regional Co-Development of Oncolytic Viruses Table 23: Immuno - Oncology Portfolio of Major Pharma & Biotech with Interest in Oncolytic Viruses Table 24: Interests of Major Pharma & Biotech in Oncolytic Viruses Table 25: First Generation Oncology Virus Companies and their Sources of Technology Table 26: Second Generation Oncology Virus Companies and their Sources of Technology Table 27: Third Generation Oncology Virus Companies and their Sources of Technology Table 28: Fourth Generation Oncology Virus Companies and their Sources of Technology Table 29: Grants, Credits & Donations Table 30: Financing by Venture Capital, Private Equity and Other Private Placements Table 31: Collaboration & Licensing Agreements Table 32: Companies Listed on Stock Exchange & Offerings Table 33: Mergers & Acquisitions
U-M holds a patent on MM - 401 and has licensed it to Ascentage Pharma, a China - based company co-founded by Wang in which the university holds equity.
The other techniques most used by pharma and biotech companies are small / wide and ultra-small angle X-ray scattering, pair distribution function (PDF), micro - and nano - 3D tomography and X-ray fluorescence and powder diffraction.
It is hard to get good information, because just like big pharma, big supplement companies have an agenda — and its to make money by selling their products.
That is certainly been shown by the performance of «Big Pharma» companies such as Eli Lilly (NYSE: LLY), Merck (NYSE: MK), and Pfizer (NYSE: PFE) in recent market action.
That is certainly been shown by the performance of «Big Pharma» companies such as Eli Lilly (NYSE: LLY), Merck (NYSE: MK), and Pfizer (NYSE: PFE) in recent -LSB-...]
We partner with our clients by offering consulting services to the organizations in the healthcare space comprising of Hospitals, Pharma and life sciences companies.
The reason for this difference is obvious: the US tort law system and overabundance of lawyers, eager to cash in on someone's agony by going after the deep - pocketed pharma companies.
a b c d e f g h i j k l m n o p q r s t u v w x y z